Evolent Health, Inc.

NYSE:EVH

Medical - Healthcare Information Services

Healthcare
$3.93 -6.00%

-$0.28 today

Market cap
$442.05M
Beta
0.83
P/E (TTM)
-1.0
EPS (TTM)
-$4.44
52W Low $2.10High $12.07

Volume 3.10M

Average 2.78M

EVH Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Evolent Health, Inc.NYSE: EVH

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares declines year over year

Q1 FY2026 weighted avg shares of 111.91M shares fell 3.0% year over year, behind the -0.8% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 2.0% from the prior quarter. Over 3 fiscal years it compounded at +6.8% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -3.0% toward the trailing-twelve-month pace of -0.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
111.91M-2.0% QoQ
Last fiscal yearDec 2025
114.21M-0.4% YoY
LTMMar 2026
114.02M-0.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.0%——
1 year-0.4%——
3-year CAGR+6.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
114.21M USD
Year-over-year change
-0.4%
4-year CAGR
+7.3%

Weighted Avg Shares vs competitors

How EVH compares with its peers on the latest reported figures

  • EVH's LTM Mar 2026 weighted avg shares of 114.02M shares is the 2nd highest of the 11 companies compared; the peer median is 84.48M shares.
  • Its year-over-year change of -0.8% is the 10th highest of 11, against a peer median of +14.4%.
  • Over three fiscal years its annual growth of +6.8% compares with a peer median of +8.4%.
EVH Competitors Peer median
Weighted Avg Shares for EVH and competitors
Company Period LTM YoY 3-year CAGR
BFLYButterfly Network, Inc.LTM Mar 2026250.79M +15.2%+7.3%
EVHEvolent Health, Inc.LTM Mar 2026114.02M -0.8%+6.8%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
REPLReplimune Group, Inc.LTM Dec 202589.05M +21.7%+15.6%
KURAKura Oncology, Inc.LTM Mar 202687.97M +1.1%+9.4%
MGTXMeiraGTx Holdings plcLTM Mar 202680.99M +13.7%+21.2%
AVBPArriVent BioPharma, Inc. Common StockLTM Mar 202640.11M +19.2%+4.7%
AMNAMN Healthcare Services, Inc.LTM Mar 202638.67M +1.1%-4.8%
HSTMHealthStream, Inc.LTM Mar 202629.94M -1.6%-0.7%
NUTXNutex Health, Inc.LTM Mar 20266.41M +23.8%+14.6%
Peer median (excluding EVH) 84.48M+14.4%+8.4%

Competitors are the stored peer set for EVH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue907.96M1.35B1.96B2.55B1.88B
Cost of Revenue657.55M1.04B1.5B2.19B1.59B
Gross Profit250.41M316.58M460.47M367.35M284.03M
Gross Margin27.6%23.4%23.4%14.4%15.1%
Research & Development027M000
Selling, General & Admin219.5M269.27M358.11M263.05M288.47M
Operating Expenses292.82M312.94M531.68M407.84M288.47M
Depreciation & Amortization60.04M90.25M123.42M123.17M115.85M
EBITDA55.66M43.75M(24.79M)84.85M(361.31M)
EBITDA Margin6.1%3.2%-1.3%3.3%-19.3%
Operating Income(42.41M)3.64M(71.21M)(40.49M)(4.44M)
Operating Margin-4.7%0.3%-3.6%-1.6%-0.2%
Interest Income407K1.37M5.26M5.54M4.19M
Interest Expense25.43M15.57M54.21M24.72M57.47M
Other Income / Expenses12.61M(65.72M)(131.19M)(22.55M)(530.2M)
Income Before Tax(29.8M)(62.08M)(202.41M)(63.04M)(534.64M)
Pre-Tax Margin-3.3%-4.6%-10.3%-2.5%-28.5%
Income Tax Expense483K(43.38M)(89.37M)(1.41M)(126K)
Net Income(37.6M)(19.16M)(113.04M)(61.62M)(534.51M)
Net Margin-4.1%-1.4%-5.8%-2.4%-28.5%
EPS (Basic)(0.36)(0.20)(1.28)(0.81)(5.07)
EPS (Diluted)(0.36)(0.20)(1.28)(0.81)(5.07)
Weighted Avg Shares86.07M93.7M111.25M114.68M114.21M
Weighted Avg Shares (Diluted)86.07M93.7M111.25M114.68M114.21M

Evolent Health, Inc.

NYSE:EVH

Intrinsic Alpha fair value

Locked

Current Price

$3.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.